Skip to main content
JAAOS Global Research & Reviews logoLink to JAAOS Global Research & Reviews
. 2026 Mar 27;10(4):e26.00023. doi: 10.5435/JAAOSGlobal-D-26-00023

Surgical Approach and Microbiologic Trends in Hip Periprosthetic Joint Infection: A Retrospective Comparison of Anterior and Posterior THA

John R Tyler 1,, Daniel Schmitt 1, William J Long 1, Samantha Bialek 1, Dana H Tran 1, Nicholas M Brown 1
PMCID: PMC13034937  PMID: 41945752

Abstract

Introduction:

Periprosthetic joint infection (PJI) is a serious complication after total hip arthroplasty (THA). Previous work has explored risk factors of infection, but few studies have evaluated whether surgical approach influences the microbiologic profile of THA PJIs.

Methods:

A retrospective review identified patients who developed PJI after primary THA between January 2007 and January 2024. The surgical approach (direct anterior vs. posterior) was determined from surgical reports. Infecting organisms were categorized as gram-positive, gram-negative, polymicrobial, or culture-negative. Clinical and microbiologic variables were compared between approaches. Among culture-positive, microbiologically homogeneous infections, multivariable logistic regression assessed the association between approach and gram-negative infection.

Results:

Eighty-three patients met inclusion criteria: 22 with anterior and 61 with posterior THAs. No significant differences were observed in age, sex, body mass index, Charlson Comorbidity Index, or SIRS score between cohorts (P > 0.05). Organism profiles were broadly similar across groups, with no statistically significant differences in specific pathogens or microbiologic categories, including gram-positive, gram-negative, or culture-negative PJIs. Although not statistically significant, polymicrobial infections were more common in the posterior cohort (13.1 vs. 4.5%, P = 0.433) and gram-negative organisms in the anterior cohort (18.2 vs. 4.9%, P = 0.076). On multivariable analysis, the surgical approach trend toward gram-negative infections remained but was not statistically significant (OR, 3.79; 95% CI, 0.74 to 19.34; P = 0.110).

Conclusion:

The surgical approach was not associated with significant differences in the infecting organism profile after THA PJI. However, the observed trend toward more gram-negative infections with the anterior approach warrants additional investigation.


Periprosthetic joint infection (PJI) remains one of the most clinically and economically burdensome complications after total hip arthroplasty (THA), with profound consequences for patient morbidity, mortality, and the healthcare system.1-3 While numerous studies have investigated risk factors of PJI, growing evidence suggests that the surgical approach itself may influence not only the risk of infection but also the causative microbiologic profile.4-6

The direct anterior approach (DAA) has gained widespread popularity because of its muscle-sparing technique, reduced postoperative pain, and potentially faster functional recovery.7-9 However, its proximity to the inguinal region, a site with dense microbial flora, has raised concerns regarding contamination risk and altered infectious profiles compared with the posterior approach.10 Emerging evidence indicates a potential association between the DAA and higher rates of gram-negative and polymicrobial PJIs,6,11 although data remain limited.

Buchalter et al6 demonstrated that the surgical approach notably affects the organism profile in THA PJIs, with anterior approaches showing a markedly higher incidence of monomicrobial gram-negative infections. However, their retrospective analysis was limited by the use of a broad “nonanterior” comparator group, rather than a direct comparison between the direct anterior and posterior approaches, and by the absence of multivariable adjustment for potential confounders. Beyond Buchalter's work, the only other study to present detailed organism-level data compared DAA with a lateral approach, not posterior, and found differences in pathogen prevalence, including higher rates of Cutibacterium avidum in DAA PJIs.12 Furthermore, multiple large database and institutional studies have compared PJI rates across surgical approaches, finding similar or modestly different risks between the direct anterior and posterior approaches, but without providing organism-level data stratified by approach.13,14 A recent systematic review and meta-analysis of organism profiles in hip PJIs likewise concluded that evidence on approach-specific microbiology remains limited and that additional, approach-stratified studies are needed.13 To our knowledge, no previous study has provided a detailed microbiologic comparison of PJIs between the direct anterior and posterior approaches in primary THA.

Given these limitations and the increasing adoption of the anterior approach, additional investigation is warranted. The purpose of this study was to determine whether surgical approach (anterior vs. posterior) is associated with differences in the infecting organism profile among patients with THA PJI. The primary outcome was the distribution of gram-negative versus gram-positive infections. Secondary outcomes included rates of polymicrobial and culture-negative infections. We hypothesized that anterior approaches would demonstrate a higher incidence of gram-negative infections compared with posterior approaches.

Methods

Study Design

After obtaining institutional review board approval, all primary THAs performed at a level 1 academic medical center between January 2007 and January 2024 were screened by manual chart review. Patients who subsequently developed PJI, defined according to Musculoskeletal Infection Society criteria, were included.15 Exclusion criteria were revision THA at index procedure, hemiarthroplasty, and cases not meeting Musculoskeletal Infection Society criteria.

All diagnoses were verified by manual chart review. Data collected included demographics (age, sex), comorbidities (body mass index [BMI], Charlson Comorbidity Index [CCI], diabetes mellitus, chronic obstructive pulmonary disease, chronic kidney disease, rheumatoid arthritis), and inflammatory response measures (systemic inflammatory response syndrome [SIRS] score at presentation). Surgical characteristics included laterality and surgical approach (anterior vs. posterior). Infectious parameters included organism(s) identified, culture results, and polymicrobial status.

Outcome Measures

The primary outcome was the distribution of infecting organisms in PJIs after THA, stratified by surgical approach. Organisms were classified into broad categories (gram-positive, gram-negative, culture-negative) and specific pathogen subtypes (e.g., methicillin-sensitive Staphylococcus aureus [MSSA], methicillin-resistant S aureus [MRSA], Enterococcus, and Pseudomonas). Polymicrobial infections were further identified and summarized by composition.

Secondary outcomes included the prevalence of polymicrobial infections, the proportion of infections with gram-negative involvement, and the rate of culture-negative PJIs. For polymicrobial infections, the presence of gram-negative organisms and Enterococcus species was further evaluated by surgical approach.

Data Analysis

Descriptive statistics were used to summarize patient demographics, surgical characteristics, and infection profiles. Continuous variables were reported as means with standard deviations while categorical variables were presented as frequencies and percentages. Group comparisons between anterior and posterior surgical approaches were conducted using the chi-square test when all expected cell counts were ≥5 and by the Fisher exact test when any expected count was <5. The Student t test was used for continuous variables.

The primary analysis compared the distribution of infecting organisms between anterior and posterior approach cohorts. Organisms were categorized into predefined groups: gram-positive, gram-negative, polymicrobial, and culture-negative. Secondary analyses evaluated the association of surgical approach with specific organisms (e.g., S aureus, Enterococcus, and Pseudomonas) and polymicrobial status. Individual polymicrobial cases were reviewed and tabulated descriptively.

To assess whether surgical approach independently predicted infection organism type, a multivariable logistic regression model was constructed with gram-negative infection as the binary outcome. The model was adjusted for patient age, sex, BMI, and CCI. Only culture-positive, microbiologically homogeneous infections were included. Four polymicrobial infections composed exclusively of gram-positive organisms were included and classified as gram-positive, as all isolates belonged to the same Gram-stain group.

All statistical tests were two-sided, with significance set at P < 0.05. Analyses were conducted using R version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria).

Patient Demographics

A total of 2721 primary THAs were performed during the study period. Of these, 83 (3.05%) developed PJIs and were included in the study, comprising 22 with anterior and 61 with posterior surgical approaches. Demographic and comorbidity data for both cohorts are summarized in Table 1.

Table 1.

Patient Demographics and SIRS Score of THA PJI by Approach

Demographics Anterior (N = 22) Posterior (N = 61) P
Age (yr)a 62.55 ± 9.71 62.08 ± 10.65 0.853
Male sex 54.50% 52.50% 1.000
BMI (kg/m2)a 34.31 ± 6.98 33.47 ± 7.71 0.640
DM 13.60% 31.10% 0.160
RA 9.10% 6.60% 0.653
COPD 13.60% 18.00% 0.751
CKD 18.20% 11.50% 0.471
CCI classificationa 2.68 ± 1.67 3.39 ± 2.53 0.145
SIRS scorea 0.45 ± 0.60 0.59 ± 0.84 0.420
a

The values are given as the mean and standard deviation.

CCI = Charlson Comorbidity Index, COPD = chronic obstructive pulmonary disease, CKD = chronic kidney disease, BMI = body mass index, DM = diabetes mellitus, PJI = periprosthetic joint infection, RA = rheumatoid arthritis, SIRS = systemic inflammatory response syndrome, THA = total hip arthroplasty

On average, patients in the anterior cohort had a slightly higher BMI (34.31 ± 6.98 vs. 33.47 ± 7.71 kg/m2, P = 0.640) and a lower CCI (2.68 ± 1.67 vs. 3.39 ± 2.53, P = 0.145), although these differences were not statistically significant. Age (62.55 ± 9.71 vs. 62.08 ± 10.65 years, P = 0.853) and SIRS score at presentation (0.45 ± 0.60 vs. 0.59 ± 0.84, P = 0.420) were also similar between groups. No significant differences were observed in sex (54.5 vs. 52.5% male, P = 1.000), diabetes mellitus (13.6 vs. 31.1%, P = 0.160), rheumatoid arthritis (9.1 vs. 6.6%, P = 0.653), chronic obstructive pulmonary disease (13.6 vs. 18.0%, P = 0.751), or chronic kidney disease (18.2 vs. 11.5%, P = 0.471).

Results

Infecting Organisms by Surgical Approach

Among patients who developed PJIs after THA, the distribution of infecting organisms was similar between anterior and posterior approaches. The most frequently isolated pathogens were S aureus (MSSA and MRSA), coagulase-negative Staphylococcus (CoNS), and Streptococcus species. Complete organism-specific data are given in Table 2.

Table 2.

Specific Infecting Organisms of THA PJI by Approach

Organism Anterior (N = 22, %) Posterior (N = 61, %) P
Coagulase-negative staph 3 (13.6) 12 (19.7) 0.749
Culture-negative PJI 3 (13.6) 7 (11.5) 0.720
Cutibacterium 3 (13.6) 2 (3.3) 0.113
E coli 0 (0.0) 1 (1.6) 1.000
Enterococcus 0 (0.0) 4 (6.6) 0.569
Klebsiella 0 (0.0) 1 (1.6) 1.000
MRSA 1 (4.5%) 6 (9.8) 0.669
MSSA 6 (27.3) 17 (27.9) 1.000
Morganella 1 (4.5) 0 (0.0) 0.265
Other/uncategorized 3 (13.6) 4 (6.6) 0.375
Proteus 1 (4.5) 1 (1.6) 0.462
Pseudomonas 0 (0.0) 1 (1.6) 1.000
Streptococcus 1 (4.5) 5 (8.2) 1.000

MRSA = methicillin-resistant Staphylococcus aureus, MSSA = methicillin-sensitive S aureus, PJI = periprosthetic joint infection, THA = total hip arthroplasty

Grouped by microbiologic classification, gram-positive organisms accounted for most infections in both cohorts, followed by culture-negative and gram-negative PJIs (Figure 1). Normalized percentages were used to visualize organism-level (Figure 2) and category-level (Figure 1) distributions independent of group size. Chi-square analysis demonstrated no significant difference in the distribution of either specific organisms (P = 0.375) or broader categories, including gram-positive, gram-negative, polymicrobial, and culture-negative infections (P = 0.437). Raw counts and statistical comparisons are provided in Table 2 (specific organisms) and Table 3 (broad categories), with no statistically significant differences observed (P > 0.05 for all comparisons).

Figure 1.

Figure 1

Chart demonstrating distribution of broad infecting organism categories in PJI cases after anterior and posterior THA, expressed as percentage of cases by approach. THA = total hip arthroplasty.

Figure 2.

Figure 2

Chart demonstrating distribution of specific infecting organisms in patients who had PJI after anterior and posterior THA, expressed as percentage of cases by approach. PJI = periprosthetic joint infection, THA = total hip arthroplasty.

Table 3.

Broad Infecting Organism Category by THA PJI by Approach

Organism Anterior (N = 22, %) Posterior (N = 61, %) P
Gram-negative 4 (18.2) 3 (4.9) 0.076
Gram-positive 14 (63.6) 43 (70.5) 0.597
Culture-negative 3 (13.6) 7 (11.5) 0.720
Polymicrobial 1 (4.5) 8 (13.1) 0.433

PJI = periprosthetic joint infection, THA = total hip arthroplasty

Specific Infecting Organisms

No statistically significant differences were observed between surgical approaches for any individual organism, including MRSA (4.5 anterior vs. 9.8% posterior; P = 0.669), MSSA (27.3 vs. 27.9%; P = 1.000), CoNS (13.6 vs. 19.7%; P = 0.749), Enterococcus (0.0 vs. 6.6%; P = 0.569), or culture-negative PJIs (13.6 vs. 11.5%; P = 0.720). The “other/uncategorized” category included rare pathogens such as Staphylococcus lugdunensis, Morganella morganii, and Acinetobacter species. No vancomycin-resistant Enterococcus, vancomycin-intermediate or vancomycin-resistant S aureus, acid-fast bacteria, or fungal infections were identified in either cohort.

Broad Infecting Organism Categories

While gram-negative PJIs were more common in the anterior cohort (18.2 vs. 4.9%), this difference was not statistically significant (P = 0.076). No significant differences were found in the rates of gram-positive (63.6 vs. 70.5%; P = 0.597), culture-negative (13.6 vs. 11.5%; P = 0.720), or polymicrobial infections (4.5 vs. 13.1%; P = 0.433) by approach (Table 3, Figure 1).

Polymicrobial Infections

One polymicrobial infection was identified in the anterior cohort, involving two gram-positive organisms: Streptococcus agalactiae and Cutibacterium acnes. Among the eight polymicrobial infections in the posterior cohort, five (62.5%) included at least one gram-negative organism and three (38%) involved Enterococcus. Although none of the polymicrobial infections in the anterior cohort involved gram-negative organisms, the difference in gram-negative involvement between anterior and posterior approaches did not reach statistical significance (0 vs. 62.5%, P = 0.444), likely due to the limited number of polymicrobial cases. Individual organisms are listed in Table 4.

Table 4.

Infecting Organisms of Polymicrobial THA PJI by Approach

Approach Organism
Posterior (n = 8)
 Case 1 Staphylococcus epidermidis, Enterobacter cloacae, Peptostreptococcus
 Case 2 MSSA, Proteus mirabilis
 Case 3 E coli, Streptococcus agalactiae, Finegoldia magna
 Case 4 MSSA, E coli, Pseudomonas aeruginosa, Enterococcus faecalis, Viridans strep, Finegoldia magna
 Case 5 2 strains of coagulase-negative Staphylococcus
 Case 6 Staphylococcus epidermidis, Enterococcus faecalis
 Case 7 Acinetobacter species, Klebsiella species, Enterococcus species, CONS
 Case 8 2 strains of coagulase-negative Staphylococcus, Peptostreptococcus
Anterior (n = 1)
 Case 9 Streptococcus agalactiae, Cutibacterium acnes

MRSA = methicillin-resistant S aureus, MSSA = methicillin-sensitive S aureus, THA = total hip arthroplasty, PJI = periprosthetic joint infection

Multivariable Analysis

Among 68 patients with microbiologically homogeneous, culture-positive PJIs, multivariable logistic regression showed that surgical approach was not a significant predictor of gram-negative infection (OR, 3.79; 95% CI, 0.74 to 19.34; P = 0.110). No other covariates, including sex (P = 0.419), age (P = 0.896), BMI (P = 0.507), or CCI (P = 0.701), were independently associated with gram-negative infection (Table 5, Figure 3).

Table 5.

Multivariable Logistic Regression Predicting Gram-negative PJI

Predictor Odds Ratio 95% CI P
Anterior approach versus posterior 3.79 0.74-19.34 0.110
Male sex versus female 1.04 0.94-1.16 0.419
Age (per year) 1.12 0.20-6.39 0.896
BMI (per unit) 1.04 0.92-1.18 0.507
CCI (per point) 0.9 0.53-1.53 0.701

Multivariable logistic regression model of predictors for gram-negative periprosthetic joint infection (PJI) in patients undergoing total hip arthroplasty. Only microbiologically homogeneous infections were included. BMI = body mass index, CCI = Charlson Comorbidity Index, CI = confidence interval, OR = odds ratio.

Figure 3.

Figure 3

Forest plot displaying ORs and 95% CIs from a multivariable logistic regression model of gram-negative infection among 68 patients who had microbiologically homogeneous, culture-positive PJIs. The model adjusts for surgical approach, sex, age, BMI, and Charlson Comorbidity Index. ORs are shown on a log scale. BMI = body mass index, CI = confidence interval, OR = odds ratio.

Discussion

While previous studies have explored patient-specific and surgery-specific risk factors of PJI, relatively few have examined whether specific surgical approach (anterior vs. posterior) influences infecting organism. In this study, we found no statistically significant differences in organism profiles between anterior and posterior THA PJIs, by either specific pathogen or broad microbiologic classification. However, there was a trend toward an increase in gram-negative organisms in the anterior approach and a higher incidence of polymicrobial infections with the posterior approach.

The most frequently identified organisms across both cohorts were S aureus (MSSA and MRSA), coagulase-negative Staphylococcus, and Streptococcus species, consistent with previous epidemiologic data on hip PJI.16,17 Gram-positive bacteria accounted for most infections in both groups; however, we observed a notable trend toward higher gram-negative infection rates in anterior THA PJIs (18.2 vs. 4.9%), which approached but did not reach statistical significance (P = 0.076). Although underpowered, this difference may be clinically meaningful and is consistent with previous findings.

Aggarwal et al18 reported markedly more gram-negative infections in direct anterior approach (DAA) THAs, potentially due to differences in soft-tissue handling, surgical exposure, or proximity to the perineum. This association is biologically plausible, given the anterior incision's location and higher likelihood of contamination with skin and enteric flora. While gram-negative PJIs are often attributed to hematogenous seeding from urinary tract infections, several authors have also reported that gram-negative organisms commonly colonize the gastrointestinal tract, genitourinary tract, and inguinal folds—areas that may be more exposed during anterior surgical approaches—potentially contributing to local surgical site contamination.1,19-23 These findings suggest that the anterior approach may introduce distinct contamination risks and warrant additional investigation in larger, multicenter cohorts.

Our multivariable analysis, adjusting for age, sex, BMI, and comorbidity burden, did not identify surgical approach as an independent predictor of gram-negative infection. This is consistent with the findings of Ashraf et al, whose systematic review and meta-analysis found no significant difference in organism profiles between DAA and other THA approaches.13 However, a key limitation of that study was its binary stratification of DAA versus nonanterior approaches. By grouping posterior, lateral, and anterolateral approaches into a single comparator group, the study introduces substantial heterogeneity, limiting anatomical specificity and interpretability. Recent studies have demonstrated that the lateral approach may carry a higher risk of PJIs compared with the posterior approach.24,25 Furthermore, the lateral approach exhibits a markedly different microbiologic spectrum and resistance pattern in PJI compared with DAA.12

By contrast, our direct comparison of anterior and posterior approaches, those most commonly used in clinical practice, offers more granular, clinically actionable insight.26 This precise stratification enhances internal validity and enables detection of approach-specific microbiologic trends that broader comparisons may obscure.

Institutional variability in perioperative protocols, infection prevention strategies, and laboratory identification techniques also likely contributes to discrepancies between studies. For example, Buchalter et al6 implemented enhanced gram-negative antimicrobial prophylaxis and vancomycin intrawound powder (VIP), interventions likely influencing infection profiles. Enhanced gram-negative antimicrobial prophylaxis has been shown to markedly reduce the risk of surgical site infection, with decreases in both gram-negative and gram-positive organisms.27 However, the clinical benefit of VIP seems to depend on concurrent use with systemic cefazolin because data from the study by Ortiz et al28 demonstrate a lack of efficacy for VIP alone without Ancef, highlighting the importance of combination prophylaxis in infection prevention protocols. Such variability is a major confounder in large systematic reviews and meta-analyses. Notably, the review by Ashraf et al did not control for differences in institutional protocols or laboratory methods, further limiting the attribution of microbiologic trends to surgical approach alone.13

Among polymicrobial cases, gram-negative organisms and Enterococcus were more commonly involved in posterior THA PJIs, although these differences were not statistically significant. Importantly, only one polymicrobial infection was identified in the anterior cohort, which severely limited the statistical power to detect meaningful differences by approach. This sole anterior case involved two gram-positive organisms: Streptococcus agalactiae and Cutibacterium acnes.

Our study contributes to the growing body of evidence evaluating the microbiologic consequences of surgical technique. Although the anterior approach has been associated with complications such as wound healing issues and lateral femoral cutaneous nerve injury, its role in altering susceptibility to specific pathogens remains uncertain.29,30 The observed trend toward increased gram-negative infections in anterior THAs merits additional investigation in larger, multicenter cohorts, particularly given implications for empiric antibiotic strategies. Future studies should avoid grouping all nonanterior approaches together and instead stratify by anterior versus posterior to better capture potential microbiologic differences. Care should be taken to standardize or control for institutional variability.

This study is not without limitations. Its retrospective design precludes causal inference, and although our sample size was adequate for detecting broad trends, it may be underpowered for subtle differences in organism frequency. Despite over 2500 THAs performed during the study period, the rarity of PJI limited our sample size. This was particularly evident in the analysis of polymicrobial infections, where only one case occurred in the anterior cohort, severely limiting statistical power to detect approach-related differences in mixed-organism profiles. Although our study included data from multiple surgeons, which may introduce variation in surgical technique and experience, all procedures adhered to standardized institutional protocols, enhancing internal consistency. However, the single-center nature of our data may limit generalizability, particularly given that PJI pathogen profiles can vary markedly by geographic region.4

Conclusions

The findings of this study suggest that anterior and posterior surgical approaches do not confer markedly different microbiologic risks in the setting of PJIs after primary THA. While gram-negative infections were more frequently observed in anterior cases, this trend did not reach statistical significance and surgical approach was not an independent predictor of gram-negative infection on multivariable analysis. As of now, these findings suggest that infection prevention and empiric treatment strategies do not support tailoring empiric treatment or prophylaxis based solely on surgical approach. However, additional multicenter studies with larger cohorts are warranted to validate these observations because multiple studies have indicated a trend toward increased gram-negative infections with the anterior approach.

Footnotes

The authors declare the following potential conflict of interests. Dr. Schmitt is a or an immediate family member serves as a paid consultant to Surgical Planning Associates/Hip Insight. Dr. Long is a or an immediate family member serves as a paid consultant to ZimmerBiomet, Sylke, and Ceramtec. Dr. Long also has or an immediate family member has stock or stock options held in Sylke and TJO, and has received financial support from Elsevier. Dr. Brown is a or an immediate family member serves as a paid consultant to Depuy, Corin, Link, and Microport. Dr. Brown is also board member/owner/officer/committee appointments: on the editorial board for JOA, Annals of Joint, and Arthroplasty Today, and is a board member of the AAOS OKU committee.

Tyler: investigation, methodology, data curation, writing—original draft, visualization. Dr. Schmitt: investigation, writing—reviewing and editing. Dr. Long: investigation, writing—reviewing and editing. Dr. Bialek: investigation, writing—reviewing and editing. Tran: investigation, writing—reviewing and editing. Dr. Brown: conceptualization, methodology, writing—reviewing and editing.

Contributor Information

Daniel Schmitt, Email: daniel.schmitt@luhs.org.

William J. Long, Email: longw@hss.edu.

Samantha Bialek, Email: Samantha.Bialek@luhs.org.

Dana H. Tran, Email: dtran9@luc.edu.

Nicholas M. Brown, Email: Nicholas.Brown002@lumc.edu.

References

  • 1.Tande AJ, Patel R: Prosthetic joint infection. Clin Microbiol Rev 2014;27:302-345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J: Economic burden of periprosthetic joint infection in the United States. J Arthroplasty 2012;27:61-5.e1. [DOI] [PubMed] [Google Scholar]
  • 3.Parvizi J, Gehrke T; International Consensus Group on Periprosthetic Joint Infection: Definition of periprosthetic joint infection. J Arthroplasty 2014;29:1331. [DOI] [PubMed] [Google Scholar]
  • 4.Aggarwal VK, Bakhshi H, Ecker NU, Parvizi J, Gehrke T, Kendoff D: Organism profile in periprosthetic joint infection: Pathogens differ at two arthroplasty infection referral centers in Europe and in the United States. J Knee Surg 2014;27:399-406. [DOI] [PubMed] [Google Scholar]
  • 5.Peel TN, Buising KL, Dowsey MM, et al. : Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy. Antimicrob Agents Chemother 2013;57:350-355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Buchalter DB, Teo GM, Kirby DJ, Aggarwal VK, Long WJ: Surgical approach to total hip arthroplasty affects the organism profile of early periprosthetic joint infections. JB JS Open Access 2020;5:e20.00111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Jewett BA, Collis DK: High complication rate with anterior total hip arthroplasties on a fracture table. Clin Orthop Relat Res 2011;469:503-507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Barrett WP, Turner SE, Leopold JP: Prospective randomized study of direct anterior vs postero-lateral approach for total hip arthroplasty. J Arthroplasty 2013;28:1634-1638. [DOI] [PubMed] [Google Scholar]
  • 9.Wang H, Liu J-F, Wang F, et al. : A comparison of the clinical efficacy of total hip arthroplasty via direct anterior approach and posterior approach: A meta-analysis. Medicine 2024;103:e39237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Christensen CP, Karthikeyan T, Jacobs CA: Greater prevalence of wound complications requiring reoperation with direct anterior approach total hip arthroplasty. J Arthroplasty 2014;29:1839-1841. [DOI] [PubMed] [Google Scholar]
  • 11.Barrett WP, Turner SE, Murphy JA, Flener JL, Alton TB: Prospective, randomized study of direct anterior approach vs posterolateral approach total hip arthroplasty: A concise 5-year follow-up evaluation. J Arthroplasty 2019;34:1139-1142. [DOI] [PubMed] [Google Scholar]
  • 12.Aichmair A, Frank BJH, Singer G, Simon S, Dominkus M, Hofstaetter JG: Differential microbiological spectrum and resistance pattern in periprosthetic hip joint infections: A matched-cohort analysis comparing direct anterior versus lateral approach. BMC Musculoskelet Disord 2022;23:72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hantouly AT, Muthu S, Lawand J, et al. : The impact of surgical approach in total hip arthroplasty on the organisms profile of periprosthetic joint infections? A systematic review and meta-analysis. Arch Orthop Trauma Surg 2025;145:293. [DOI] [PubMed] [Google Scholar]
  • 14.Acuña AJ, Do MT, Samuel LT, Grits D, Otero JE, Kamath AF: Periprosthetic joint infection rates across primary total hip arthroplasty surgical approaches: A systematic review and meta-analysis of 653,633 procedures. Arch Orthop Trauma Surg 2022;142:2965-2977. [DOI] [PubMed] [Google Scholar]
  • 15.Parvizi J, Tan TL, Goswami K, et al. : The 2018 definition of periprosthetic hip and knee infection: An evidence-based and validated criteria. J Arthroplasty 2018;33:1309-14.e2. [DOI] [PubMed] [Google Scholar]
  • 16.Fröschen FS, Randau TM, Franz A, Molitor E, Hischebeth GTR: Microbiological profiles of patients with periprosthetic joint infection of the hip or knee. Diagnostics 2022;12:1654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Tai DBG, Patel R, Abdel MP, Berbari EF, Tande AJ: Microbiology of hip and knee periprosthetic joint infections: A database study. Clin Microbiol Infect 2022;28:255-259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Aggarwal VK, Weintraub S, Klock J, et al. : 2019 frank Stinchfield award: A comparison of prosthetic joint infection rates between direct anterior and non-anterior approach total hip arthroplasty. Bone Jt J 2019;101-B(6_Suppl_B):2-8. [DOI] [PubMed] [Google Scholar]
  • 19.Norton TD, Skeete F, Dubrovskaya Y, Phillips MS, Bosco JD, III, Mehta SA: Orthopedic surgical site infections: Analysis of causative bacteria and implications for antibiotic stewardship. Am J Orthop (Belle Mead NJ) 2014;43:E89-E92. [PubMed] [Google Scholar]
  • 20.Aboltins CA, Dowsey MM, Buising KL, et al. : Gram-negative prosthetic joint infection treated with debridement, prosthesis retention and antibiotic regimens including a fluoroquinolone. Clin Microbiol Infect 2011;17:862-867. [DOI] [PubMed] [Google Scholar]
  • 21.Weintrob AC, Roediger MP, Barber M, et al. : Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized patients. Infect Control Hosp Epidemiol 2010;31:330-337. [DOI] [PubMed] [Google Scholar]
  • 22.Canny GO, McCormick BA: Bacteria in the intestine, helpful residents or enemies from within? Infect Immun 2008;76:3360-3373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, et al. : The urinary tract microbiome in health and disease. Eur Urol Focus 2018;4:128-138. [DOI] [PubMed] [Google Scholar]
  • 24.Berstock JR, Blom AW, Beswick AD: A systematic review and meta-analysis of complications following the posterior and lateral surgical approaches to total hip arthroplasty. Ann R Coll Surg Engl 2015;97:11-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Castioni D, Galasso O, Iannò B, Mercurio M, Gasparini G: Posterior versus lateral surgical approach: Functionality and quality of life after total hip arthroplasty in a matched cohort study. BMC Musculoskelet Disord 2021;22(suppl 2):932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Chechik O, Khashan M, Lador R, Salai M, Amar E: Surgical approach and prosthesis fixation in hip arthroplasty world wide. Arch Orthop Trauma Surg 2013;133:1595-1600. [DOI] [PubMed] [Google Scholar]
  • 27.Bosco JA, Prince Rainier RT, Catanzano AJ, Stachel AG, Phillips MS: Expanded gram-negative antimicrobial prophylaxis reduces surgical site infections in hip arthroplasty. J Arthroplasty 2016;31:616-621. [DOI] [PubMed] [Google Scholar]
  • 28.Ortiz D, III, Teo GM, Lygrisse K, Aggarwal VK, Long WJ: Increased rate of early periprosthetic joint infection in total hip arthroplasty with the use of alternatives to Cefazolin despite additional gram-negative coverage. Arthroplasty Today 2022;14:183-188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Hax J, Leuthard L, Nauer S, Stadelmann VA, Leunig M, Rüdiger HA: Treatment options for persistent lateral femoral cutaneous nerve lesions after total hip arthroplasty via the direct anterior approach: Retrospective analysis with clinical assessment. Int Orthop 2025;49:1107-1117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Wilson JM, Hadley ML, Ledford CK, Bingham JS, Taunton MJ: The fate of the patient with superficial dehiscence following direct anterior total hip arthroplasty. J Arthroplasty 2023;38:S420-S425. [DOI] [PubMed] [Google Scholar]

Articles from JAAOS Global Research & Reviews are provided here courtesy of Wolters Kluwer Health

RESOURCES